Treatment of tendopathies with tropisetron

Rheumatology International

Volumn 22, Issue 6, 2002, Pages 219-221

  Stratz, Thomas ^a   Varga, Boglarka ^a   Müller, Wolfgang ^a  

^a Hochrhein Inst fur Rehab Forsch   (Germany)

Author keywords

5 HT3 receptor antagonist; Tendopathy; Treatment

Indexed keywords

ANESTHETIC AGENT; CORTICOSTEROID; NEUROKININ; PRILOCAINE; SEROTONIN 3 ANTAGONIST; SUBSTANCE P; TROPISETRON;

ANALGESIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MEDIATOR RELEASE; NOCICEPTIVE RECEPTOR; PERIARTHRITIS; PRIORITY JOURNAL; RECEPTOR BLOCKING; TENDON DISEASE; TREATMENT OUTCOME;

EID: 0036430321     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-002-0233-8     Document Type: Article

References (19)

1. Ali Z, Wu G, Kozlov A, Barasi S (1996) The role of 5-HT3 in nociceptive processing in the rat spinal cord: Results from behavioural and electrophysiological studies. Neurosci Lett 208:203-207
2. Ambesh SP, Dubey PK, Sinha PK (1999) Ondansetron pre-treatment to alleviate pain on propofol injection: A randomized, controlled, double-blind study. Anesth Analg 89:197-199
3. Arnalich F, de Miguel E, Perez-Ayala C, Martinez M, Vazquez JJ, Gijon-Banos J et al (1994) Neuropeptides and interleukin-6 in human joint inflammation; relationship between intraarticular substance P and interleukin-5 concentration. Neurosci Lett 170:251-254
4. Covas MJ, Pinto LA, Pereiro Da Silva JA, Vitorino RM (1995) Effects of the neuropeptide, substance P, on lymphocyte proliferation in rheumatoid arthritis. J Int Med Res 431-438
5. Färber L, Stratz T, Müller W (1998) New aspects for the medical treatment of results of a double-blind, randomized, placebo-controlled multi-centre trial evaluating the efficacy and tolerability of the 5-HT3 antagonist tropisetron in primary fibromyalgia. Z Rheumatol 57 [Suppl 1]:30
6. Giordano J, Daleo C, Sacks SM (1998) Topical ondansetron attenuates nociceptive and inflammatory effects of intradermal capsaicin in humans. Eur J Pharmacol 354:13-14
7. Giordano J, Rogers LV (1989) Peripherally administered serotonin 5-HT3 receptor antagonists reduce inflammatory pain in rats. Eur J Pharmacol 170:83-86
8. Glaum SR, Proudfit HK, Andersen EG (1990) 5-HT3 receptors modulate spinal nociceptive reflexes. Brain Res 510:12-16
9. Greenshaw AJ, Silverstone PH (1997) The non-anti-emefic uses of serotonin 5-HT3-receptor antagonists. Drug 55:20-39
10. Levine JD, Clark R, Devor M, Helms C, Moskowitz MA, Basbaum AI (1984) Intraneuronal substance P contributes to the severity of experimental arthritis. Science 226:547-549
11. Locatelli L, Sacerdote P, Mantegazza P, Panerai AE (1993) Effect of ibuprofen and transforming growth factor-beta on human monocyte and polymorphonuclear cells. Int J Immunopharmacol 15:833-838
12. Lotz M, Carson DA, Vaughan JH (1987) Substance P activation of rheumatoid synoviocytes: Neural pathway in pathogenesis of arthritis. Science 235:893-895
13. Menkes CJ, Renoux M, Laoussadi S, Maoborgne A, Bruxelle J, Cesselin F (1993) Substance P levels in the synovium fluid from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 20:714-717
14. Müller W, Stratz T, Schochat T, Mennet P (1994) Die therapie der fibromyalgie mit 5-HT3-rezeptor-antagonisten. Z Rheumatol 53 [Suppl 1]:24
15. Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126-131
16. Saria A, Javorsky F, Humpel C, Gamse R (1990) 5-HT3-receptor antagonists inhibit sensory neuropeptide release from the rat spinal cord. Neuroreport 1:104-106
17. Stratz T, Färber L, Müller W (in press) Local treatment of tendinopathies: A comparison between tropisetron and depot corticosteroids combined with local anesthetics. Scand J Rheum
18. Stratz T, Müller W (2000) The use of 5-HT3 receptor antagonists in various rheumatic diseases - A clue to the mechanisms of action of these agents in fibromyalgia? Scand J Rheumatol 29 [Suppl 113]:66-71
19. Stratz T, Schochat T, Hrycaj P, Lacki J, Färber L, Schweiger Ch et al (1994) Die therapie der generalisierten tendomyo-pathie (Fibromyalgie) durch blockierung der 5-HT3-rezeptoren. Z Rheumatol 53:335-338